Murdo Gordon - Net Worth and Insider Trading

Murdo Gordon Net Worth

The estimated net worth of Murdo Gordon is at least $12 Million dollars as of 2024-05-01. Murdo Gordon is the EVP, Global Commercial Ops of Amgen Inc and owns about 44,308 shares of Amgen Inc (AMGN) stock worth over $12 Million. Details can be seen in Murdo Gordon's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Murdo Gordon has not made any transactions after 2023-08-10 and currently still holds the listed stock(s).

Transaction Summary of Murdo Gordon

To

Murdo Gordon Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Murdo Gordon owns 2 companies in total, including Amgen Inc (AMGN) , and Bristol-Myers Squibb Co (BMY) .

Click here to see the complete history of Murdo Gordon’s form 4 insider trades.

Insider Ownership Summary of Murdo Gordon

Ticker Comapny Transaction Date Type of Owner
AMGN Amgen Inc 2023-08-10 EVP Global Commercial Ops
BMY Bristol-Myers Squibb Co 2015-05-05 SVP & Head of Worldwide Markets

Murdo Gordon Latest Holdings Summary

Murdo Gordon currently owns a total of 1 stock. Murdo Gordon owns 44,308 shares of Amgen Inc (AMGN) as of August 10, 2023, with a value of $12 Million.

Latest Holdings of Murdo Gordon

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AMGN Amgen Inc 2023-08-10 44,308 274.13 12,146,152

Holding Weightings of Murdo Gordon


Murdo Gordon Form 4 Trading Tracker

According to the SEC Form 4 filings, Murdo Gordon has made a total of 1 transactions in Amgen Inc (AMGN) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Amgen Inc is the sale of 9,558 shares on August 10, 2023, which brought Murdo Gordon around $3 Million.

Insider Trading History of Murdo Gordon

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Murdo Gordon Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Murdo Gordon Ownership Network

Ownership Network List of Murdo Gordon

No Data

Ownership Network Relation of Murdo Gordon


Murdo Gordon Owned Company Details

What does Amgen Inc do?

Who are the key executives at Amgen Inc?

Murdo Gordon is the EVP Global Commercial Ops of Amgen Inc. Other key executives at Amgen Inc include SVP & CCO Nancy A. Grygiel , SVP & Gen. Counsel & Secy. Jonathan P Graham , and VP & Finance & CAO Matthew C. Busch .

Amgen Inc (AMGN) Insider Trades Summary

Over the past 18 months, Murdo Gordon made 1 insider transaction in Amgen Inc (AMGN) with a net sale of 9,558. Other recent insider transactions involving Amgen Inc (AMGN) include a net sale of 2,641 shares made by Nancy A. Grygiel , a net sale of 10,000 shares made by Jonathan P Graham , and a net sale of 387 shares made by Rachna Khosla .

In summary, during the past 3 months, insiders sold 0 shares of Amgen Inc (AMGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 22,586 shares of Amgen Inc (AMGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 22,586 shares.

Amgen Inc (AMGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Amgen Inc Insider Transactions

No Available Data

Murdo Gordon Mailing Address

Above is the net worth, insider trading, and ownership report for Murdo Gordon. You might contact Murdo Gordon via mailing address: C/o Bristol-myers Squibb Company, 345 Park Ave, New York Ny 10154.

Discussions on Murdo Gordon

No discussions yet.